These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

704 related items for PubMed ID: 25385105

  • 21. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.
    Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A.
    J Antimicrob Chemother; 2007 Nov; 60(5):1124-30. PubMed ID: 17884829
    [Abstract] [Full Text] [Related]

  • 22. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study.
    Kofteridis DP, Valachis A, Dimopoulou D, Maraki S, Christidou A, Mantadakis E, Samonis G.
    J Infect Chemother; 2014 May; 20(5):293-7. PubMed ID: 24703709
    [Abstract] [Full Text] [Related]

  • 23. The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents.
    Mills JP, Talati NJ, Alby K, Han JH.
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):55-60. PubMed ID: 26455382
    [Abstract] [Full Text] [Related]

  • 24. Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China.
    Huang Y, Zhuang S, Du M.
    Infection; 2007 Oct; 35(5):339-45. PubMed ID: 17721736
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The risk factors, antimicrobial resistance patterns, and outcomes associated with extended-spectrum β-lactamases-Producing pathogens in pediatric urinary tract infection.
    He XT, Chang CN, Yu CH, Wang CC.
    Pediatr Neonatol; 2024 May; 65(3):242-248. PubMed ID: 37951832
    [Abstract] [Full Text] [Related]

  • 28. Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections.
    Yang YS, Ku CH, Lin JC, Shang ST, Chiu CH, Yeh KM, Lin CC, Chang FY.
    J Microbiol Immunol Infect; 2010 Jun; 43(3):194-9. PubMed ID: 21291846
    [Abstract] [Full Text] [Related]

  • 29. [Klebsiella pneumoniae Infections in the Intensive Care Unit: Risk Factors Related to Carbapenem Resistance and Patient Mortality].
    Büyüktuna SA, Hasbek M, Çelik C, Ünlüsavuran M, Avcı O, Baltacı S, Fırtına Topcu K, Elaldı N.
    Mikrobiyol Bul; 2020 Jul; 54(3):378-391. PubMed ID: 32755515
    [Abstract] [Full Text] [Related]

  • 30. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.
    Borer A, Saidel-Odes L, Eskira S, Nativ R, Riesenberg K, Livshiz-Riven I, Schlaeffer F, Sherf M, Peled N.
    Am J Infect Control; 2012 Jun; 40(5):421-5. PubMed ID: 21906844
    [Abstract] [Full Text] [Related]

  • 31. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome.
    Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori E, Leone F, Fadda G, Cauda R.
    Antimicrob Agents Chemother; 2006 Feb; 50(2):498-504. PubMed ID: 16436702
    [Abstract] [Full Text] [Related]

  • 32. Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections.
    Vachvanichsanong P, McNeil EB, Dissaneewate P.
    Epidemiol Infect; 2020 Dec 17; 149():e12. PubMed ID: 33327984
    [Abstract] [Full Text] [Related]

  • 33. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K, Raz-Pasteur A, Finkelstein R, Neuberger A, Shachor-Meyouhas Y, Oren I, Kassis I.
    J Hosp Infect; 2013 Apr 17; 83(4):307-13. PubMed ID: 23313086
    [Abstract] [Full Text] [Related]

  • 34. Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure.
    Chia JH, Su LH, Lee MH, Kuo AJ, Shih NY, Siu LK, Wu TL.
    Microb Drug Resist; 2010 Dec 17; 16(4):317-25. PubMed ID: 20524901
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of Extended Spectrum Beta-Lactamase Producing Klebsiella Pneumoniae Isolated From Urinary Tract Infected Patients.
    Chaudhary P, Bhandari D, Thapa K, Thapa P, Shrestha D, Chaudhary HK, Shrestha A, Parajuli H, Gupta BP.
    J Nepal Health Res Counc; 2016 May 17; 14(33):111-115. PubMed ID: 27885293
    [Abstract] [Full Text] [Related]

  • 36. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation.
    Bergamasco MD, Barroso Barbosa M, de Oliveira Garcia D, Cipullo R, Moreira JC, Baia C, Barbosa V, Abboud CS.
    Transpl Infect Dis; 2012 Apr 17; 14(2):198-205. PubMed ID: 22093103
    [Abstract] [Full Text] [Related]

  • 37. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
    Liu C, Liu L, Jin MM, Hu YB, Cai X, Wan L, Zhang HY, Li RY, Wu XJ.
    Curr Med Sci; 2022 Feb 17; 42(1):68-76. PubMed ID: 34985611
    [Abstract] [Full Text] [Related]

  • 38. Clinical and microbiological characteristics of nosocomial, healthcare-associated, and community-acquired Klebsiella pneumoniae infections in Guangzhou, China.
    Le T, Wang L, Zeng C, Fu L, Liu Z, Hu J.
    Antimicrob Resist Infect Control; 2021 Feb 25; 10(1):41. PubMed ID: 33632338
    [Abstract] [Full Text] [Related]

  • 39. Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study.
    Shilo S, Assous MV, Lachish T, Kopuit P, Bdolah-Abram T, Yinnon AM, Wiener-Well Y.
    Infection; 2013 Apr 25; 41(2):503-9. PubMed ID: 23271210
    [Abstract] [Full Text] [Related]

  • 40. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
    Martinez P, Garzón D, Mattar S.
    Braz J Infect Dis; 2012 Apr 25; 16(5):420-5. PubMed ID: 22964287
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.